Mesenchymal Stem Cells

Children with autism spectrum disorder (ASD) can suffer from immune dysregulation and inflammation, and now, a STEM CELLS Translational Medicine article from the lab of Neil H.

A new STEM CELLS Translational Medicine article from the laboratory of

Recent research from the lab of Sandra Muntión (IBSAL‐Hospital Universitario de Salamanca, Salamanca, Spain) aimed to analyze changes induced in human CD34+ hematopoietic stem/progenitor cells following treatment with extracellular vesicles derived from mesenchymal stem cells (MSC-EVs).

New evidence suggests that repeated MSC application protects motor neurons and neuromuscular junctions by inhibiting major cell death pathways in ALS rats

Advanced clinical trials will require the definition of the immune potency of mesenchymal stem cell (MSCs) destined to be administered to human patients and to this end, researchers from the laboratories of Raghavan Chinnadurai and

A recent Perspectives article from the laboratory of Biju Parekkadan (Rutgers University, New Jersey, USA) discusses the development of an ex vivo mesenchymal stem cell (MSC) therapeutic adapting principles of classical molecular drug pharm

Trial of allogeneic MSC infusion before removal of the cancerous prostate establishes that cells do not home to primary tumor sites in sufficient levels

A new study supports chronic pancreatitis patient MSCs as autologous cell therapy in patients undergoing total pancreatectomy with islet transplantation

Metabolic syndrome may impair the therapeutic ability of mesenchymal stem cell-derived extracellular vesicles by promoting a proinflammatory EV profile

Macrophages educated to a proregenerative M2‐like state after exposure to MSC-derived extracellular vesicles promote regeneration in a mouse tendon rupture model